Astonea Labs Ltd IPO: Issue Details, Open/Close Date | Research 360 by Motilal Oswal
Back arrow

Astonea Labs

CMP

366.20

4.00 (-)

  • DRHP
₹135

Offer Price

₹ 37.67 Cr

Issue Size

₹ 1,35,000

Min Investment

1,000

Lot size

Time Line

  • 27
    May 2025
    Open
  • 29
    May 2025
    Close
  • 30
    May 2025
    Finalisation of Basis of Allotment
  • 02
    Jun 2025
    Initiation of Refunds
  • 02
    Jun 2025
    Transfer of Shares to Demat Account
  • 03
    Jun 2025
    Listing Date

Shares Offered

Number of Times Subscribed

Objects of the Offer

  • Expand our scope by adding more products.

  • Broaden and deepen presence in existing product portfolio.

  • Develop and grow our export division.

  • Increase by targeting unexplored markets.

  • Leveraging our marketing skills and relationships.

Products & Services

  • The Company specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products.

Strengths

  • Our experienced management and dedicated employee base.

  • Scalable business model.

  • Wide and diverse range of product offerings.

  • Quality Service.

Risks

  • The Company has not satisfied the annual OMFUA, under which the FDA assesses and collects fees from qualifying manufacturers of OTC monograph drugs which is mandatory to be paid by all the manufacturers of OTC drugs.

  • There have been some instances of delayed and non-filings in the past with the Registrar of Companies which may attract penalties.

  • The company is dependent on third parties for the supply of raw materials and such third parties could fails in meeting their obligations, which may have a material adverse effect on its business, results of operations and financial condition. Further its 35.47%, 41.96%, 55.74% and 33.90% of its total purchases are derived from its top 10 suppliers for Financial Years ended on March 31, 2024, March 31, 2023, March 31, 2022 and for the period ended December 31, 2024 respectively.

  • The Company, its Promoters, Directors, and Group Companies are party to certain legal proceedings. Any adverse outcome in such proceedings may have an adverse impact on its reputation, business, financial condition, results of operations, and cash flows.

  • Its business is significantly dependent on the revenue generated by manufacturing and selling the pharmaceuticals, which constitutes a substantial portion of its sales and such dependence exposes it to various risks that could materially affect its business operations, financial condition, and results of operations.

Company Promoters

Promoters Holding

Issue For IPO
26.12%
Pre Holding

98.42%

Post Holding

72.30%

Top Promoters Holding

Financials

All values in Cr

Mar-2022 Mar-2023 Mar-2024 3-Yr trend
Revenue 30.06 (-) 67.05 (123.10%) 80.19 (19.60%)
Gross Profit 4.37 (-) 5.01 (14.70%) 9.08 (81.20%)
Net Income 0.25 (-) 0.67 (168.00%) 3.81 (468.70%)
Assets 37.08 (-) 44.28 (19.40%) 54.67 (23.50%)
Liabilities 29.59 (-) 36.12 (22.10%) 42.70 (18.20%)

Peers

Company Name Revenue (Cr) Net Profit (Cr) Assets (Cr) Liabilities (Cr) ROE EPS BVPS Current Ratio Debt to Assets
Astonea Labs Limited 80.19 3.81 54.67 42.70 0.00 0.00 15.75 2.09 0.78
Beta Drugs limited 295.71 36.44 254.10 254.10 23.19 37.90 163.43 14.33 0.07

Book Running Managers

  • Oneview Corporate Advisors Pvt Ltd

Registrar & Transfer Agent

KFin Techologies Ltd

Karvy Selenium Tow-B,
31&32 Financial Dist,
Nanakramguda - Hyderabad-500032
Phone 1: 91-40-67162222 Phone 2: 18003454001 Fax: 91-40-23001153/23420814

Company Contact Information

H.No.1358 1st Floor Sector-22B,
,
Chandigarh - 160022
Phone : +91-98883 02323 Email : cs@astonea.org https://www.astonea.org/

Offer Related Information

Public issue of upto 27,90,000 equity shares of face value of Rs. 10/- each ("Equity Shares") of Astonea Labs Limited ("Astonea" or the "Company" or the "Issuer") for cash at a price of Rs. 135/- per equity share including a share premium of Rs. 125/- per equity share (the "Issue Price") aggregating to Rs. 37.67 crores ("the Issue"), of which 1,44,000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 135/- per equity share including a share premium of Rs. 125/- per equity... More

Astonea Labs FAQ's

The shares of Astonea Labs were first listed on the stock exchanges on June 26, 2024.

The total issue size of the Astonea Labs IPO was 1,10,00,000 shares, amounting to Rs. 132 crore. they

The minimum lot size for Astonea Labs public issue was 125 shares.

The price band of the IPO of Astonea Labs was Rs. 114 to Rs. 120 per equity share.

Astonea Labs IPO is a public issue through which the company raised approximately Rs. 132 crore by issuing around 1.1 crore equity shares to the public. After a successful IPO, the company’s shares are currently listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), where they are freely traded without restrictions.

Bigshare Services Private Limited is the registrar and share transfer agent of Astonea Labs IPO.

Download Our App On: